Effect of sacubitril/valsartan on cardiac remodeling compared with other renin –angiotensin system inhibitors: a difference-in-difference analysis of propensity-score matched samples
ConclusionIn HFrEF patients treated with beta-blockers, sacubitril/valsartan is associated with a relative greater benefit in LV reverse remodeling indices than other RAS inhibitors.Graphical abstract (Source: Clinical Research in Cardiology)
Source: Clinical Research in Cardiology - September 21, 2023 Category: Cardiology Source Type: research
Left ventricular reverse remodeling following initiation of sacubitril/valsartan for heart failure with reduced ejection fraction and low blood pressure
In conclusion, significant LV reverse remodeling occurred after initiation of sacubitril/valsartan, even in HF patients with LVEF < 50% and systolic blood pressure ≤ 100 mmHg. (Source: Heart and Vessels)
Source: Heart and Vessels - September 21, 2023 Category: Cardiology Source Type: research
Effect of sacubitril/valsartan on cardiac remodeling compared with other renin –angiotensin system inhibitors: a difference-in-difference analysis of propensity-score matched samples
ConclusionIn HFrEF patients treated with beta-blockers, sacubitril/valsartan is associated with a relative greater benefit in LV reverse remodeling indices than other RAS inhibitors.Graphical abstract (Source: Clinical Research in Cardiology)
Source: Clinical Research in Cardiology - September 21, 2023 Category: Cardiology Source Type: research
Left ventricular reverse remodeling following initiation of sacubitril/valsartan for heart failure with reduced ejection fraction and low blood pressure
In conclusion, significant LV reverse remodeling occurred after initiation of sacubitril/valsartan, even in HF patients with LVEF < 50% and systolic blood pressure ≤ 100 mmHg. (Source: Heart and Vessels)
Source: Heart and Vessels - September 21, 2023 Category: Cardiology Source Type: research
